Global Lancets Market Growth 2020-2025


  • Apr 2020
  • |
  • 184
  • |
  • Pharmaceuticals and Healthcare

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of Lancets will have significant change from previous year. By the most conservative estimates of global Lancets market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 2055 million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Lancets market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Lancets market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Lancets, covering the supply chain analysis, impact assessment to the Lancets market size growth rate in several scenarios, and the measures to be undertaken by Lancets companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Safety Lancets

Homecare Lancets

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Cholesterol Tests

Glucose Tests

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Roche

Nipro

Lifescan

Bayer

Abbott

BD

Terumo

B. Braun

I-SENS

ARKRAY

SANNUO

Yuwell

Yicheng

Omron

Smiths Medical

AgaMatrix

Edan

Sarstedt

Infopia

Greiner Bio One

Narang Medical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Lancets consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Lancets market by identifying its various subsegments.

Focuses on the key global Lancets manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Lancets with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Lancets submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

1.8 What is the Impact of Covid-19 Outbreak On the Lancets?

1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.

1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.

1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Lancets Market Size in 2020, by Scenario

1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Lancets Consumption 2015-2025

2.1.2 Lancets Consumption CAGR by Region

2.2 Lancets Segment by Type

2.2.1 Safety Lancets

2.2.2 Homecare Lancets

2.3 Lancets Consumption by Type

2.3.1 Global Lancets Consumption Market Share by Type (2015-2020)

2.3.2 Global Lancets Revenue and Market Share by Type (2015-2020)

2.3.3 Global Lancets Sale Price by Type (2015-2020)

2.4 Lancets Segment by Application

2.4.1 Cholesterol Tests

2.4.2 Glucose Tests

2.4.3 Others

2.5 Lancets Consumption by Application

2.5.1 Global Lancets Consumption Market Share by Type (2015-2020)

2.5.2 Global Lancets Value and Market Share by Type (2015-2020)

2.5.3 Global Lancets Sale Price by Type (2015-2020)

3 Global Lancets by Company

3.1 Global Lancets Sales Market Share by Company

3.1.1 Global Lancets Sales by Company (2018-2020)

3.1.2 Global Lancets Sales Market Share by Company (2018-2020)

3.2 Global Lancets Revenue Market Share by Company

3.2.1 Global Lancets Revenue by Company (2018-2020)

3.2.2 Global Lancets Revenue Market Share by Company (2018-2020)

3.3 Global Lancets Sale Price by Company

3.4 Global Lancets Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Lancets Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Lancets Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Lancets by Regions

4.1 Lancets by Regions

4.2 Americas Lancets Consumption Growth

4.3 APAC Lancets Consumption Growth

4.4 Europe Lancets Consumption Growth

4.5 Middle East & Africa Lancets Consumption Growth

5 Americas

5.1 Americas Lancets Consumption by Countries

5.1.1 Americas Lancets Consumption by Countries (2015-2020)

5.1.2 Americas Lancets Value by Countries (2015-2020)

5.2 Americas Lancets Consumption by Type

5.3 Americas Lancets Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Lancets Consumption by Regions

6.1.1 APAC Lancets Consumption by Regions (2015-2020)

6.1.2 APAC Lancets Value by Regions (2015-2020)

6.2 APAC Lancets Consumption by Type

6.3 APAC Lancets Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Lancets by Countries

7.1.1 Europe Lancets Consumption by Countries (2015-2020)

7.1.2 Europe Lancets Value by Countries (2015-2020)

7.2 Europe Lancets Consumption by Type

7.3 Europe Lancets Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Lancets by Countries

8.1.1 Middle East & Africa Lancets Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Lancets Value by Countries (2015-2020)

8.2 Middle East & Africa Lancets Consumption by Type

8.3 Middle East & Africa Lancets Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Lancets Distributors

10.3 Lancets Customer

11 Global Lancets Market Forecast

11.1 Global Lancets Consumption Forecast (2021-2025)

11.2 Global Lancets Forecast by Regions

11.2.1 Global Lancets Forecast by Regions (2021-2025)

11.2.2 Global Lancets Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Lancets Forecast by Type

11.8 Global Lancets Forecast by Application

12 Key Players Analysis

12.1 Roche

12.1.1 Company Information

12.1.2 Lancets Product Offered

12.1.3 Roche Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Roche Latest Developments

12.2 Nipro

12.2.1 Company Information

12.2.2 Lancets Product Offered

12.2.3 Nipro Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Nipro Latest Developments

12.3 Lifescan

12.3.1 Company Information

12.3.2 Lancets Product Offered

12.3.3 Lifescan Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Lifescan Latest Developments

12.4 Bayer

12.4.1 Company Information

12.4.2 Lancets Product Offered

12.4.3 Bayer Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Bayer Latest Developments

12.5 Abbott

12.5.1 Company Information

12.5.2 Lancets Product Offered

12.5.3 Abbott Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Abbott Latest Developments

12.6 BD

12.6.1 Company Information

12.6.2 Lancets Product Offered

12.6.3 BD Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 BD Latest Developments

12.7 Terumo

12.7.1 Company Information

12.7.2 Lancets Product Offered

12.7.3 Terumo Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Terumo Latest Developments

12.8 B. Braun

12.8.1 Company Information

12.8.2 Lancets Product Offered

12.8.3 B. Braun Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 B. Braun Latest Developments

12.9 I-SENS

12.9.1 Company Information

12.9.2 Lancets Product Offered

12.9.3 I-SENS Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 I-SENS Latest Developments

12.10 ARKRAY

12.10.1 Company Information

12.10.2 Lancets Product Offered

12.10.3 ARKRAY Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 ARKRAY Latest Developments

12.11 SANNUO

12.11.1 Company Information

12.11.2 Lancets Product Offered

12.11.3 SANNUO Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 SANNUO Latest Developments

12.12 Yuwell

12.12.1 Company Information

12.12.2 Lancets Product Offered

12.12.3 Yuwell Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.12.4 Main Business Overview

12.12.5 Yuwell Latest Developments

12.13 Yicheng

12.13.1 Company Information

12.13.2 Lancets Product Offered

12.13.3 Yicheng Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.13.4 Main Business Overview

12.13.5 Yicheng Latest Developments

12.14 Omron

12.14.1 Company Information

12.14.2 Lancets Product Offered

12.14.3 Omron Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.14.4 Main Business Overview

12.14.5 Omron Latest Developments

12.15 Smiths Medical

12.15.1 Company Information

12.15.2 Lancets Product Offered

12.15.3 Smiths Medical Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.15.4 Main Business Overview

12.15.5 Smiths Medical Latest Developments

12.16 AgaMatrix

12.16.1 Company Information

12.16.2 Lancets Product Offered

12.16.3 AgaMatrix Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.16.4 Main Business Overview

12.16.5 AgaMatrix Latest Developments

12.17 Edan

12.17.1 Company Information

12.17.2 Lancets Product Offered

12.17.3 Edan Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.17.4 Main Business Overview

12.17.5 Edan Latest Developments

12.18 Sarstedt

12.18.1 Company Information

12.18.2 Lancets Product Offered

12.18.3 Sarstedt Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.18.4 Main Business Overview

12.18.5 Sarstedt Latest Developments

12.19 Infopia

12.19.1 Company Information

12.19.2 Lancets Product Offered

12.19.3 Infopia Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.19.4 Main Business Overview

12.19.5 Infopia Latest Developments

12.20 Greiner Bio One

12.20.1 Company Information

12.20.2 Lancets Product Offered

12.20.3 Greiner Bio One Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.20.4 Main Business Overview

12.20.5 Greiner Bio One Latest Developments

12.21 Narang Medical

12.21.1 Company Information

12.21.2 Lancets Product Offered

12.21.3 Narang Medical Lancets Sales, Revenue, Price and Gross Margin (2018-2020)

12.21.4 Main Business Overview

12.21.5 Narang Medical Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Lancets Market Size in 2020, by Scenario

Table 2. COVID-19: Measures to be Undertaken by Lancets Companies

Table 3. Research Methodology

Table 4. Data Source

Table 5. Lancets Consumption CAGR by Region 2015-2025 ($ Millions)

Table 6. Major Players of Safety Lancets

Table 7. Major Players of Homecare Lancets

Table 8. Global Consumption Sales by Type (2015-2020)

Table 9. Global Lancets Consumption Market Share by Type (2015-2020)

Table 10. Global Lancets Revenue by Type (2015-2020) ($ million)

Table 11. Global Lancets Value Market Share by Type (2015-2020) ($ Millions)

Table 12. Global Lancets Sale Price by Type (2015-2020)

Table 13. Global Consumption Sales by Application (2015-2020)

Table 14. Global Lancets Consumption Market Share by Application (2015-2020)

Table 15. Global Lancets Value by Application (2015-2020)

Table 16. Global Lancets Value Market Share by Application (2015-2020)

Table 17. Global Lancets Sale Price by Application (2015-2020)

Table 18. Global Lancets Sales by Company (2017-2019) (M Units)

Table 19. Global Lancets Sales Market Share by Company (2017-2019)

Table 20. Global Lancets Revenue by Company (2017-2019) ($ Millions)

Table 21. Global Lancets Revenue Market Share by Company (2017-2019)

Table 22. Global Lancets Sale Price by Company (2017-2019)

Table 23. Global Lancets Manufacturing Base Distribution and Sales Area by Manufacturers

Table 24. Players Lancets Products Offered

Table 25. Lancets Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 26. Global Lancets Consumption by Regions 2015-2020 (M Units)

Table 27. Global Lancets Consumption Market Share by Regions 2015-2020

Table 28. Global Lancets Value by Regions 2015-2020 ($ Millions)

Table 29. Global Lancets Value Market Share by Regions 2015-2020

Table 30. Americas Lancets Consumption by Countries (2015-2020) (M Units)

Table 31. Americas Lancets Consumption Market Share by Countries (2015-2020)

Table 32. Americas Lancets Value by Countries (2015-2020) ($ Millions)

Table 33. Americas Lancets Value Market Share by Countries (2015-2020)

Table 34. Americas Lancets Consumption by Type (2015-2020) (M Units)

Table 35. Americas Lancets Consumption Market Share by Type (2015-2020)

Table 36. Americas Lancets Consumption by Application (2015-2020) (M Units)

Table 37. Americas Lancets Consumption Market Share by Application (2015-2020)

Table 38. APAC Lancets Consumption by Countries (2015-2020) (M Units)

Table 39. APAC Lancets Consumption Market Share by Countries (2015-2020)

Table 40. APAC Lancets Value by Regions (2015-2020) ($ Millions)

Table 41. APAC Lancets Value Market Share by Regions (2015-2020)

Table 42. APAC Lancets Consumption by Type (2015-2020) (M Units)

Table 43. APAC Lancets Consumption Market Share by Type (2015-2020)

Table 44. APAC Lancets Consumption by Application (2015-2020) (M Units)

Table 45. APAC Lancets Consumption Market Share by Application (2015-2020)

Table 46. Europe Lancets Consumption by Countries (2015-2020) (M Units)

Table 47. Europe Lancets Consumption Market Share by Countries (2015-2020)

Table 48. Europe Lancets Value by Countries (2015-2020) ($ Millions)

Table 49. Europe Lancets Value Market Share by Countries (2015-2020)

Table 50. Europe Lancets Consumption by Type (2015-2020) (M Units)

Table 51. Europe Lancets Consumption Market Share by Type (2015-2020)

Table 52. Europe Lancets Consumption by Application (2015-2020) (M Units)

Table 53. Europe Lancets Consumption Market Share by Application (2015-2020)

Table 54. Middle East & Africa Lancets Consumption by Countries (2015-2020) (M Units)

Table 55. Middle East & Africa Lancets Consumption Market Share by Countries (2015-2020)

Table 56. Middle East & Africa Lancets Value by Countries (2015-2020) ($ Millions)

Table 57. Middle East & Africa Lancets Value Market Share by Countries (2015-2020)

Table 58. Middle East & Africa Lancets Consumption by Type (2015-2020) (M Units)

Table 59. Middle East & Africa Lancets Consumption Market Share by Type (2015-2020)

Table 60. Middle East & Africa Lancets Consumption by Application (2015-2020) (M Units)

Table 61. Middle East & Africa Lancets Consumption Market Share by Application (2015-2020)

Table 62. Lancets Distributors List

Table 63. Lancets Customer List

Table 64. Global Lancets Consumption Forecast by Countries (2021-2025) (M Units)

Table 65. Global Lancets Consumption Market Forecast by Regions

Table 66. Global Lancets Value Forecast by Countries (2021-2025) ($ Millions)

Table 67. Global Lancets Value Market Share Forecast by Regions

Table 68. Global Lancets Consumption Forecast by Type (2021-2025) (M Units)

Table 69. Global Lancets Consumption Market Share Forecast by Type (2021-2025)

Table 70. Global Lancets Value Forecast by Type (2021-2025) ($ Millions)

Table 71. Global Lancets Value Market Share Forecast by Type (2021-2025)

Table 72. Global Lancets Consumption Forecast by Application (2021-2025) (M Units)

Table 73. Global Lancets Consumption Market Share Forecast by Application (2021-2025)

Table 74. Global Lancets Value Forecast by Application (2021-2025) ($ Millions)

Table 75. Global Lancets Value Market Share Forecast by Application (2021-2025)

Table 76. Roche Product Offered

Table 77. Roche Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 78. Roche Main Business

Table 79. Roche Latest Developments

Table 80. Roche Basic Information, Company Total Revenue (in $ million), Lancets Manufacturing Base, Sales Area and Its Competitors

Table 81. Nipro Product Offered

Table 82. Nipro Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 83. Nipro Main Business

Table 84. Nipro Latest Developments

Table 85. Nipro Basic Information, Company Total Revenue (in $ million), Lancets Manufacturing Base, Sales Area and Its Competitors

Table 86. Lifescan Product Offered

Table 87. Lifescan Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 88. Lifescan Main Business

Table 89. Lifescan Latest Developments

Table 90. Lifescan Basic Information, Company Total Revenue (in $ million), Lancets Manufacturing Base, Sales Area and Its Competitors

Table 91. Bayer Product Offered

Table 92. Bayer Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 93. Bayer Main Business

Table 94. Bayer Latest Developments

Table 95. Bayer Basic Information, Company Total Revenue (in $ million), Lancets Manufacturing Base, Sales Area and Its Competitors

Table 96. Abbott Product Offered

Table 97. Abbott Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 98. Abbott Main Business

Table 99. Abbott Latest Developments

Table 100. Abbott Basic Information, Company Total Revenue (in $ million), Lancets Manufacturing Base, Sales Area and Its Competitors

Table 101. BD Product Offered

Table 102. BD Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 103. BD Main Business

Table 104. BD Latest Developments

Table 105. BD Basic Information, Company Total Revenue (in $ million), Lancets Manufacturing Base, Sales Area and Its Competitors

Table 106. Terumo Product Offered

Table 107. Terumo Basic Information, Company Total Revenue (in $ million), Lancets Manufacturing Base, Sales Area and Its Competitors

Table 108. Terumo Main Business

Table 109. Terumo Latest Developments

Table 110. Terumo Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 111. B. Braun Product Offered

Table 112. B. Braun Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 113. B. Braun Main Business

Table 114. B. Braun Latest Developments

Table 115. B. Braun Basic Information, Company Total Revenue (in $ million), Lancets Manufacturing Base, Sales Area and Its Competitors

Table 116. I-SENS Product Offered

Table 117. I-SENS Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 118. I-SENS Main Business

Table 119. I-SENS Latest Developments

Table 120. I-SENS Basic Information, Company Total Revenue (in $ million), Lancets Manufacturing Base, Sales Area and Its Competitors

Table 121. ARKRAY Product Offered

Table 122. ARKRAY Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 123. ARKRAY Main Business

Table 124. ARKRAY Latest Developments

Table 125. ARKRAY Basic Information, Company Total Revenue (in $ million), Lancets Manufacturing Base, Sales Area and Its Competitors

Table 126. SANNUO Product Offered

Table 127. SANNUO Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 128. SANNUO Main Business

Table 129. SANNUO Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 130. SANNUO Latest Developments

Table 131. Yuwell Product Offered

Table 132. Yuwell Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 133. Yuwell Main Business

Table 134. Yuwell Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 135. Yuwell Latest Developments

Table 136. Yicheng Product Offered

Table 137. Yicheng Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 138. Yicheng Main Business

Table 139. Yicheng Latest Developments

Table 140. Yicheng Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 141. Omron Product Offered

Table 142. Omron Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 143. Omron Main Business

Table 144. Omron Latest Developments

Table 145. Omron Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 146. Smiths Medical Product Offered

Table 147. Smiths Medical Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 148. Smiths Medical Main Business

Table 149. Smiths Medical Latest Developments

Table 150. Smiths Medical Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 151. AgaMatrix Product Offered

Table 152. AgaMatrix Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 153. AgaMatrix Main Business

Table 154. AgaMatrix Latest Developments

Table 155. AgaMatrix Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 156. Edan Product Offered

Table 157. Edan Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 158. Edan Main Business

Table 159. Edan Latest Developments

Table 160. Edan Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 161. Sarstedt Product Offered

Table 162. Sarstedt Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 163. Sarstedt Main Business

Table 164. Sarstedt Latest Developments

Table 165. Sarstedt Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 166. Infopia Product Offered

Table 167. Infopia Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 168. Infopia Main Business

Table 169. Infopia Latest Developments

Table 170. Infopia Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 171. Greiner Bio One Product Offered

Table 172. Greiner Bio One Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 173. Greiner Bio One Main Business

Table 174. Greiner Bio One Latest Developments

Table 175. Greiner Bio One Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 176. Narang Medical Product Offered

Table 177. Narang Medical Lancets Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)

Table 178. Narang Medical Main Business

Table 179. Narang Medical Latest Developments

Table 180. Narang Medical Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Lancets

Figure 2. Lancets Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Lancets Consumption Growth Rate 2015-2025 (M Units)

Figure 5. Global Lancets Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Safety Lancets

Figure 7. Product Picture of Homecare Lancets

Figure 8. Global Lancets Consumption Market Share by Type (2015-2020)

Figure 9. Global Lancets Value Market Share by Type (2015-2020)

Figure 10. Lancets Consumed in Cholesterol Tests

Figure 11. Global Lancets Market: Cholesterol Tests (2015-2020) (M Units)

Figure 12. Global Lancets Market: Cholesterol Tests (2015-2020) ($ Millions)

Figure 13. Lancets Consumed in Glucose Tests

Figure 14. Global Lancets Market: Glucose Tests (2015-2020) (M Units)

Figure 15. Global Lancets Market: Glucose Tests (2015-2020) ($ Millions)

Figure 16. Lancets Consumed in Others

Figure 17. Global Lancets Market: Others (2015-2020) (M Units)

Figure 18. Global Lancets Market: Others (2015-2020) ($ Millions)

Figure 19. Global Lancets Consumption Market Share by Application (2015-2020)

Figure 20. Global Lancets Value Market Share by Application (2015-2020)

Figure 21. Global Lancets Sales Market Share by Company in 2017

Figure 22. Global Lancets Sales Market Share by Company in 2019

Figure 23. Global Lancets Revenue Market Share by Company in 2017

Figure 24. Global Lancets Revenue Market Share by Company in 2019

Figure 25. Global Lancets Sale Price by Company in 2019

Figure 26. Global Lancets Consumption Market Share by Regions 2015-2020

Figure 27. Global Lancets Value Market Share by Regions 2015-2020

Figure 28. Americas Lancets Consumption 2015-2020 (M Units)

Figure 29. Americas Lancets Value 2015-2020 ($ Millions)

Figure 30. APAC Lancets Consumption 2015-2020 (M Units)

Figure 31. APAC Lancets Value 2015-2020 ($ Millions)

Figure 32. Europe Lancets Consumption 2015-2020 (M Units)

Figure 33. Europe Lancets Value 2015-2020 ($ Millions)

Figure 34. Middle East & Africa Lancets Consumption 2015-2020 (M Units)

Figure 35. Middle East & Africa Lancets Value 2015-2020 ($ Millions)

Figure 36. Americas Lancets Consumption Market Share by Countries in 2019

Figure 37. Americas Lancets Value Market Share by Countries in 2019

Figure 38. Americas Lancets Consumption Market Share by Type in 2019

Figure 39. Americas Lancets Consumption Market Share by Application in 2019

Figure 40. United States Lancets Consumption Growth 2015-2020 (M Units)

Figure 41. United States Lancets Value Growth 2015-2020 ($ Millions)

Figure 42. Canada Lancets Consumption Growth 2015-2020 (M Units)

Figure 43. Canada Lancets Value Growth 2015-2020 ($ Millions)

Figure 44. Mexico Lancets Consumption Growth 2015-2020 (M Units)

Figure 45. Mexico Lancets Value Growth 2015-2020 ($ Millions)

Figure 46. APAC Lancets Consumption Market Share by Countries in 2019

Figure 47. APAC Lancets Value Market Share by Regions in 2019

Figure 48. APAC Lancets Consumption Market Share by Type in 2019

Figure 49. APAC Lancets Consumption Market Share by Application in 2019

Figure 50. China Lancets Consumption Growth 2015-2020 (M Units)

Figure 51. China Lancets Value Growth 2015-2020 ($ Millions)

Figure 52. Japan Lancets Consumption Growth 2015-2020 (M Units)

Figure 53. Japan Lancets Value Growth 2015-2020 ($ Millions)

Figure 54. Korea Lancets Consumption Growth 2015-2020 (M Units)

Figure 55. Korea Lancets Value Growth 2015-2020 ($ Millions)

Figure 56. Southeast Asia Lancets Consumption Growth 2015-2020 (M Units)

Figure 57. Southeast Asia Lancets Value Growth 2015-2020 ($ Millions)

Figure 58. India Lancets Consumption Growth 2015-2020 (M Units)

Figure 59. India Lancets Value Growth 2015-2020 ($ Millions)

Figure 60. Australia Lancets Consumption Growth 2015-2020 (M Units)

Figure 61. Australia Lancets Value Growth 2015-2020 ($ Millions)

Figure 62. Europe Lancets Consumption Market Share by Countries in 2019

Figure 63. Europe Lancets Value Market Share by Countries in 2019

Figure 64. Europe Lancets Consumption Market Share by Type in 2019

Figure 65. Europe Lancets Consumption Market Share by Application in 2019

Figure 66. Germany Lancets Consumption Growth 2015-2020 (M Units)

Figure 67. Germany Lancets Value Growth 2015-2020 ($ Millions)

Figure 68. France Lancets Consumption Growth 2015-2020 (M Units)

Figure 69. France Lancets Value Growth 2015-2020 ($ Millions)

Figure 70. UK Lancets Consumption Growth 2015-2020 (M Units)

Figure 71. UK Lancets Value Growth 2015-2020 ($ Millions)

Figure 72. Italy Lancets Consumption Growth 2015-2020 (M Units)

Figure 73. Italy Lancets Value Growth 2015-2020 ($ Millions)

Figure 74. Russia Lancets Consumption Growth 2015-2020 (M Units)

Figure 75. Russia Lancets Value Growth 2015-2020 ($ Millions)

Figure 76. Middle East & Africa Lancets Consumption Market Share by Countries in 2019

Figure 77. Middle East & Africa Lancets Value Market Share by Countries in 2019

Figure 78. Middle East & Africa Lancets Consumption Market Share by Type in 2019

Figure 79. Middle East & Africa Lancets Consumption Market Share by Application in 2019

Figure 80. Egypt Lancets Consumption Growth 2015-2020 (M Units)

Figure 81. Egypt Lancets Value Growth 2015-2020 ($ Millions)

Figure 82. South Africa Lancets Consumption Growth 2015-2020 (M Units)

Figure 83. South Africa Lancets Value Growth 2015-2020 ($ Millions)

Figure 84. Israel Lancets Consumption Growth 2015-2020 (M Units)

Figure 85. Israel Lancets Value Growth 2015-2020 ($ Millions)

Figure 86. Turkey Lancets Consumption Growth 2015-2020 (M Units)

Figure 87. Turkey Lancets Value Growth 2015-2020 ($ Millions)

Figure 88. GCC Countries Lancets Consumption Growth 2015-2020 (M Units)

Figure 89. GCC Countries Lancets Value Growth 2015-2020 ($ Millions)

Figure 90. Global Lancets Consumption Growth Rate Forecast (2021-2025) (M Units)

Figure 91. Global Lancets Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 92. Americas Lancets Consumption 2021-2025 (M Units)

Figure 93. Americas Lancets Value 2021-2025 ($ Millions)

Figure 94. APAC Lancets Consumption 2021-2025 (M Units)

Figure 95. APAC Lancets Value 2021-2025 ($ Millions)

Figure 96. Europe Lancets Consumption 2021-2025 (M Units)

Figure 97. Europe Lancets Value 2021-2025 ($ Millions)

Figure 98. Middle East & Africa Lancets Consumption 2021-2025 (M Units)

Figure 99. Middle East & Africa Lancets Value 2021-2025 ($ Millions)

Figure 100. United States Lancets Consumption 2021-2025 (M Units)

Figure 101. United States Lancets Value 2021-2025 ($ Millions)

Figure 102. Canada Lancets Consumption 2021-2025 (M Units)

Figure 103. Canada Lancets Value 2021-2025 ($ Millions)

Figure 104. Mexico Lancets Consumption 2021-2025 (M Units)

Figure 105. Mexico Lancets Value 2021-2025 ($ Millions)

Figure 106. Brazil Lancets Consumption 2021-2025 (M Units)

Figure 107. Brazil Lancets Value 2021-2025 ($ Millions)

Figure 108. China Lancets Consumption 2021-2025 (M Units)

Figure 109. China Lancets Value 2021-2025 ($ Millions)

Figure 110. Japan Lancets Consumption 2021-2025 (M Units)

Figure 111. Japan Lancets Value 2021-2025 ($ Millions)

Figure 112. Korea Lancets Consumption 2021-2025 (M Units)

Figure 113. Korea Lancets Value 2021-2025 ($ Millions)

Figure 114. Southeast Asia Lancets Consumption 2021-2025 (M Units)

Figure 115. Southeast Asia Lancets Value 2021-2025 ($ Millions)

Figure 116. India Lancets Consumption 2021-2025 (M Units)

Figure 117. India Lancets Value 2021-2025 ($ Millions)

Figure 118. Australia Lancets Consumption 2021-2025 (M Units)

Figure 119. Australia Lancets Value 2021-2025 ($ Millions)

Figure 120. Germany Lancets Consumption 2021-2025 (M Units)

Figure 121. Germany Lancets Value 2021-2025 ($ Millions)

Figure 122. France Lancets Consumption 2021-2025 (M Units)

Figure 123. France Lancets Value 2021-2025 ($ Millions)

Figure 124. UK Lancets Consumption 2021-2025 (M Units)

Figure 125. UK Lancets Value 2021-2025 ($ Millions)

Figure 126. Italy Lancets Consumption 2021-2025 (M Units)

Figure 127. Italy Lancets Value 2021-2025 ($ Millions)

Figure 128. Russia Lancets Consumption 2021-2025 (M Units)

Figure 129. Russia Lancets Value 2021-2025 ($ Millions)

Figure 130. Spain Lancets Consumption 2021-2025 (M Units)

Figure 131. Spain Lancets Value 2021-2025 ($ Millions)

Figure 132. Egypt Lancets Consumption 2021-2025 (M Units)

Figure 133. Egypt Lancets Value 2021-2025 ($ Millions)

Figure 134. South Africa Lancets Consumption 2021-2025 (M Units)

Figure 135. South Africa Lancets Value 2021-2025 ($ Millions)

Figure 136. Israel Lancets Consumption 2021-2025 (M Units)

Figure 137. Israel Lancets Value 2021-2025 ($ Millions)

Figure 138. Turkey Lancets Consumption 2021-2025 (M Units)

Figure 139. Turkey Lancets Value 2021-2025 ($ Millions)

Figure 140. GCC Countries Lancets Consumption 2021-2025 (M Units)

Figure 141. GCC Countries Lancets Value 2021-2025 ($ Millions)

Figure 142. Roche Lancets Market Share (2018-2020)

Figure 143. Nipro Lancets Market Share (2018-2020)

Figure 144. Lifescan Lancets Market Share (2018-2020)

Figure 145. Bayer Lancets Market Share (2018-2020)

Figure 146. Abbott Lancets Market Share (2018-2020)

Figure 147. BD Lancets Market Share (2018-2020)

Figure 148. Terumo Lancets Market Share (2018-2020)

Figure 149. B. Braun Lancets Market Share (2018-2020)

Figure 150. I-SENS Lancets Market Share (2018-2020)

Figure 151. ARKRAY Lancets Market Share (2018-2020)

Figure 152. SANNUO Lancets Market Share (2018-2020)

Figure 153. Yuwell Lancets Market Share (2018-2020)

Figure 154. Yicheng Lancets Market Share (2018-2020)

Figure 155. Omron Lancets Market Share (2018-2020)

Figure 156. Smiths Medical Lancets Market Share (2018-2020)

Figure 157. AgaMatrix Lancets Market Share (2018-2020)

Figure 158. Edan Lancets Market Share (2018-2020)

Figure 159. Sarstedt Lancets Market Share (2018-2020)

Figure 160. Infopia Lancets Market Share (2018-2020)

Figure 161. Greiner Bio One Lancets Market Share (2018-2020)

Figure 162. Narang Medical Lancets Market Share (2018-2020)

Sample Request is not available